Skip to main content
Fig. 3 | BMC Pharmacology and Toxicology

Fig. 3

From: Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trial

Fig. 3

Outcomes in ICU Interventions and Control Groups. Graph A illustrates the average duration of ICU stays, with the intervention group having a mean stay of 3.3 days and the control group 14.5 days, each with standard deviations of 0.57 and 6.58 days, respectively. Graph B depicts the percentage of patients requiring mechanical ventilation. In the intervention group, none of the patients required mechanical ventilation, while all patients in the control group did, which is also statistically highly significant, as denoted by the four asterisks. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us